The rapid development of effective vaccines against COVID-19 is an extraordinary achievement. However, no medical product can ever be considered risk-free. Several countries have a pharmacovigilance system that detects, assesses, understands, and …
Despite the stunning speed with which highly effective and safe vaccines have been developed, the emergence of new variants of SARS‑CoV‑2 causes high rates of (re)infection, a major impact on health care services, and a slowdown to the socio-economic …
Vaccine effectiveness (VE) against emerging SARS-CoV-2 variants is a growing issue. The aim of this work is to evaluate the impact of the COVID-19 additional/booster dose against COVID-19-related symptoms, hospitalization, and death using …
Operativa la piattaforma Covida, ideata e realizzata all'Unical